Ambion and Rosetta Genomics Announce Licensing and Commercialization Deal To Advance microRNA Research
Agreement provides Ambion access to Rosetta's database of proprietary microRNA sequences for a range of applications in medical research
13-Sep-2005 -
Rosetta Genomics Ltd. and Ambion, Inc. announced a collaborative
licensing agreement that will provide Ambion access to proprietary microRNA
(miRNA) sequences discovered and owned by Rosetta Genomics. The agreement
enables Ambion to adapt its microRNA platforms to detect, quantify, ...
diseases
gene expression
microRNAs
+1